Ticker League

Pfizer (PFE) Free Cash Flow Bridge

Pinpoint what moved Pfizer's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

-15.47%

OCF YoY

-14.33%

Capex YoY

-9.68%

FCF Conversion Δ

-1.1 pp

Free cash flow bridge for Pfizer (PFE) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: −$1.74B

FCF bridge breakdown for Pfizer (PFE) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$11.22B
  • Operating Cash Flow−$2.00B
  • Capital Expenditure$268.00M
  • Free Cash Flow$9.48B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology